Manufacturing Facilities
Delivering high quality products across the globe

11 manufacturing facilities across 4 countries

Monroe, US

Established in 2015
The facility upon commercialization will manufacture:
  • Oral solids
  • Injectables

Markets

The US

Annual Capacity

Oral solids: 300 – 400 million tablets and capsules annually

Injectables: 20 – 25 million vials and pre-filled syringes

Goa, India

Glenmark has two manufacturing facilities at Goa, India which manufacture:
  • Oral – solids
  • Semi-solids
  • Hormones (oral solids)

ISO 14001: 2004 approved

Regulatory Approvals

  • U.S. FDA
  • MHRA UK
  • ANVISA Brazil
  • TPD Canada
  • MCC South Africa
  • WHO – GMP

Markets

North America, Western Europe

Annual Capacity

Oral solid dosages (OSD): 4000 Mn tablets and 608 Mn capsules

Semi-solids: 21 Mn tubes

Hormone: 400 Mn tablets

Baddi, India

Commenced operations in 2005.
The facility caters to the production of:
  • Oral solids and liquid orals
  • External preparations like lotions and creams
  • Respiratory segment products

Regulatory Approvals

  • U.S. FDA
  • MHRA UK
  • ANVISA Brazil
  • TPD Canada
  • DDA Nepal
  • Ukrainian GMP
  • NDA Uganda
  • FDA Ghana
  • CHMP Kenya
  • MCC South Africa
  • TGA Australia
  • WHO - GMP

Markets

US, Europe , India , semi-regulated markets for specific dosage forms

Nalagarh, India

The plant focuses on manufacturing:
  • Oral liquids
  • Semi-solids

ISO 14001: 2004 approved 

Regulatory Approvals

  • ANVISA Brazil
  • NDA Uganda
  • WHO-GMP
  • Local FDA

Markets

India, Asia, Africa

Annual Capacity

Oral liquids: 45 million

Semi-solids: 45 million

Lotions: 22 million

Sikkim, India

Established in 2012.
The facility is focused on the manufacturing of:
  • Oral solid dosages

Regulatory Approvals

  • FDA (India)

Markets

India

Annual Capacity

Oral Solid dosages : 835 million tablets 

Nashik, India

This was Glenmark’s first manufacturing facility which commenced operations in 1983
The facility is equipped to manufacture products across various dosage forms:
  • Oral solids
  • Liquid orals
  • External creams
  • Powders

ISO 14001: 2004 approved 

Regulatory Approvals

  • ANVISA Brazil
  • MOH Ukraine
  • INVIMA Columbia
  • NDA Uganda
  • MOH Nigeria
  • TFDA Tanzania
  • MOH Ethiopia
  • MCC South Africa
  • MOH Congo
  • MOH Oman
  • WHO – GMP

Markets

Exports to emerging markets including , Asia, India, Africa, Russia, CIS, Latin America

Indore, India

Commenced operations in 2009
The facility is equipped to manufacture products across various dosage forms:
  • Oral solids
  • Semi-solids
  • Injectable
  • Immunosuppressant

ISO 14001: 2004 approved 

Regulatory Approvals

  • U.S. FDA
  • MHRA UK
  • ANVISA Brazil
  • WHO – GMP

Markets

North America, European regions

Annual Capacity

Oral solid dosages: 1440 M tablets per annum

Pilar, Argentina

The Glenmark manufacturing site at Pilar, Argentina is focused on the manufacturing of Oncology Injectables and is spread across 30,000 sq. ft
  • It serves as a global hub for the manufacturing of Lyophilized and Liquid Injectables used in oncology therapies

Regulatory Approvals

  • ANMAT Argentina
  • MERCOSUR
  • U.S FDA
  • MHRA – UK
  • ANVISA Brazil
  • Gulf GCC

Markets

Latin America, Asia, Africa

Annual Capacity

3.5 Mn vials

Vysoke Myto, Czech Republic

The facility manufactures:
  • Solid - orals
  • Semi - solids (Ointments)

Regulatory Approvals

  • Manufacturing licence for medicinal products (Issued by SUKL)
  • Distribution licence for medicinal products (Issued by SUKL)
  • Certificate of GMP Compliance of Manufacturer (Issued by SUKL)
  • Certificate of GMP Compliance of a Manufacturer (Issued by USKVBL)

Markets

European Union countries

Annual Capacity

Oral solid dosages: 144 Mn tablets

Ointments and creams: 1.5 Mn tubes

Aurangabad, India

This facility is designed to produce:
  • Cytotoxic oral solid products

Annual Capacity

14 million tablets annually

Quality at Glenmark

Setting new benchmarks through delivery of high quality products across all geographies
Know More